CENOVUS ENERGY INC (CVE) Fundamental Analysis & Valuation

NYSE:CVE • CA15135U1093

Current stock price

27.17 USD
+0.29 (+1.08%)
Last:

This CVE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CVE Profitability Analysis

1.1 Basic Checks

  • CVE had positive earnings in the past year.
  • In the past year CVE had a positive cash flow from operations.
  • Each year in the past 5 years CVE has been profitable.
  • Each year in the past 5 years CVE had a positive operating cash flow.
CVE Yearly Net Income VS EBIT VS OCF VS FCFCVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 6.17%, CVE is in the better half of the industry, outperforming 69.38% of the companies in the same industry.
  • With a decent Return On Equity value of 12.38%, CVE is doing good in the industry, outperforming 69.38% of the companies in the same industry.
  • CVE has a better Return On Invested Capital (6.85%) than 64.11% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CVE is significantly below the industry average of 23.10%.
Industry RankSector Rank
ROA 6.17%
ROE 12.38%
ROIC 6.85%
ROA(3y)6.41%
ROA(5y)6.35%
ROE(3y)12.34%
ROE(5y)12.52%
ROIC(3y)8.35%
ROIC(5y)10.5%
CVE Yearly ROA, ROE, ROICCVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • With a Profit Margin value of 7.88%, CVE perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CVE has declined.
  • The Operating Margin of CVE (9.54%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of CVE has declined.
  • CVE has a Gross Margin of 34.22%. This is comparable to the rest of the industry: CVE outperforms 44.98% of its industry peers.
  • In the last couple of years the Gross Margin of CVE has declined.
Industry RankSector Rank
OM 9.54%
PM (TTM) 7.88%
GM 34.22%
OM growth 3Y-16.68%
OM growth 5YN/A
PM growth 3Y-6.34%
PM growth 5YN/A
GM growth 3Y-11.56%
GM growth 5Y-11%
CVE Yearly Profit, Operating, Gross MarginsCVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

5

2. CVE Health Analysis

2.1 Basic Checks

  • CVE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • CVE has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CVE has been increased compared to 5 years ago.
  • CVE has a worse debt/assets ratio than last year.
CVE Yearly Shares OutstandingCVE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
CVE Yearly Total Debt VS Total AssetsCVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • CVE has an Altman-Z score of 2.70. This is not the best score and indicates that CVE is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.70, CVE is doing good in the industry, outperforming 76.08% of the companies in the same industry.
  • The Debt to FCF ratio of CVE is 4.28, which is a neutral value as it means it would take CVE, 4.28 years of fcf income to pay off all of its debts.
  • CVE has a Debt to FCF ratio of 4.28. This is in the better half of the industry: CVE outperforms 70.81% of its industry peers.
  • A Debt/Equity ratio of 0.44 indicates that CVE is not too dependend on debt financing.
  • CVE has a Debt to Equity ratio (0.44) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 4.28
Altman-Z 2.7
ROIC/WACC0.95
WACC7.18%
CVE Yearly LT Debt VS Equity VS FCFCVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B

2.3 Liquidity

  • CVE has a Current Ratio of 1.57. This is a normal value and indicates that CVE is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of CVE (1.57) is better than 66.51% of its industry peers.
  • A Quick Ratio of 1.04 indicates that CVE should not have too much problems paying its short term obligations.
  • CVE has a Quick ratio (1.04) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.04
CVE Yearly Current Assets VS Current LiabilitesCVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

5

3. CVE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 30.49% over the past year.
  • CVE shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.45% yearly.
  • The Revenue has decreased by -8.44% in the past year.
  • Measured over the past years, CVE shows a very strong growth in Revenue. The Revenue has been growing by 30.31% on average per year.
EPS 1Y (TTM)30.49%
EPS 3Y-10.45%
EPS 5YN/A
EPS Q2Q%614.29%
Revenue 1Y (TTM)-8.44%
Revenue growth 3Y-9.43%
Revenue growth 5Y30.31%
Sales Q2Q%-15.06%

3.2 Future

  • Based on estimates for the next years, CVE will show a very strong growth in Earnings Per Share. The EPS will grow by 20.99% on average per year.
  • The Revenue is expected to decrease by -5.57% on average over the next years.
EPS Next Y-54.6%
EPS Next 2Y-6.64%
EPS Next 3Y7.94%
EPS Next 5Y20.99%
Revenue Next Year-16.99%
Revenue Next 2Y-6.2%
Revenue Next 3Y-5.57%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CVE Yearly Revenue VS EstimatesCVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20B 40B 60B
CVE Yearly EPS VS EstimatesCVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 -2 4

2

4. CVE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 17.64, CVE is valued on the expensive side.
  • CVE's Price/Earnings is on the same level as the industry average.
  • CVE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.21.
  • The Price/Forward Earnings ratio is 38.89, which means the current valuation is very expensive for CVE.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CVE is on the same level as its industry peers.
  • CVE is valuated expensively when we compare the Price/Forward Earnings ratio to 23.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.64
Fwd PE 38.89
CVE Price Earnings VS Forward Price EarningsCVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CVE is valued a bit cheaper than the industry average as 61.24% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CVE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 21.39
EV/EBITDA 8.23
CVE Per share dataCVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.64%
EPS Next 3Y7.94%

5

5. CVE Dividend Analysis

5.1 Amount

  • CVE has a Yearly Dividend Yield of 2.15%. Purely for dividend investing, there may be better candidates out there.
  • CVE's Dividend Yield is comparable with the industry average which is at 3.16.
  • Compared to an average S&P500 Dividend Yield of 1.89, CVE has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.15%

5.2 History

  • On average, the dividend of CVE grows each year by 65.35%, which is quite nice.
  • CVE has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)65.35%
Div Incr Years0
Div Non Decr Years0
CVE Yearly Dividends per shareCVE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

  • CVE pays out 36.70% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of CVE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP36.7%
EPS Next 2Y-6.64%
EPS Next 3Y7.94%
CVE Yearly Income VS Free CF VS DividendCVE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B 6B
CVE Dividend Payout.CVE Dividend Payout, showing the Payout Ratio.CVE Dividend Payout.PayoutRetained Earnings

CVE Fundamentals: All Metrics, Ratios and Statistics

CENOVUS ENERGY INC

NYSE:CVE (4/7/2026, 3:50:04 PM)

27.17

+0.29 (+1.08%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-19
Earnings (Next)04-30
Inst Owners55.94%
Inst Owner Change-0.01%
Ins Owners0.62%
Ins Owner ChangeN/A
Market Cap51.08B
Revenue(TTM)49.70B
Net Income(TTM)3.92B
Analysts81.9
Price Target23.33 (-14.13%)
Short Float %4.73%
Short Ratio4.02
Dividend
Industry RankSector Rank
Dividend Yield 2.15%
Yearly Dividend0.56
Dividend Growth(5Y)65.35%
DP36.7%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-13
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.1%
Min EPS beat(2)28.15%
Max EPS beat(2)40.05%
EPS beat(4)4
Avg EPS beat(4)67.87%
Min EPS beat(4)25.67%
Max EPS beat(4)177.6%
EPS beat(8)5
Avg EPS beat(8)23.22%
EPS beat(12)8
Avg EPS beat(12)16.31%
EPS beat(16)10
Avg EPS beat(16)8.98%
Revenue beat(2)0
Avg Revenue beat(2)-13.68%
Min Revenue beat(2)-22.39%
Max Revenue beat(2)-4.97%
Revenue beat(4)0
Avg Revenue beat(4)-9.24%
Min Revenue beat(4)-22.39%
Max Revenue beat(4)-4.15%
Revenue beat(8)2
Avg Revenue beat(8)-4.53%
Revenue beat(12)4
Avg Revenue beat(12)-3.39%
Revenue beat(16)8
Avg Revenue beat(16)2.77%
PT rev (1m)0%
PT rev (3m)8.41%
EPS NQ rev (1m)33.13%
EPS NQ rev (3m)4.68%
EPS NY rev (1m)0%
EPS NY rev (3m)-43.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.03%
Valuation
Industry RankSector Rank
PE 17.64
Fwd PE 38.89
P/S 1.43
P/FCF 21.39
P/OCF 8.63
P/B 2.25
P/tB 2.47
EV/EBITDA 8.23
EPS(TTM)1.54
EY5.67%
EPS(NY)0.7
Fwd EY2.57%
FCF(TTM)1.27
FCFY4.67%
OCF(TTM)3.15
OCFY11.58%
SpS19
BVpS12.09
TBVpS10.98
PEG (NY)N/A
PEG (5Y)N/A
Graham Number20.47
Profitability
Industry RankSector Rank
ROA 6.17%
ROE 12.38%
ROCE 8.3%
ROIC 6.85%
ROICexc 7.19%
ROICexgc 7.6%
OM 9.54%
PM (TTM) 7.88%
GM 34.22%
FCFM 6.68%
ROA(3y)6.41%
ROA(5y)6.35%
ROE(3y)12.34%
ROE(5y)12.52%
ROIC(3y)8.35%
ROIC(5y)10.5%
ROICexc(3y)8.81%
ROICexc(5y)11.28%
ROICexgc(3y)9.38%
ROICexgc(5y)12.09%
ROCE(3y)10.15%
ROCE(5y)12.76%
ROICexgc growth 3Y-30.32%
ROICexgc growth 5YN/A
ROICexc growth 3Y-29.98%
ROICexc growth 5YN/A
OM growth 3Y-16.68%
OM growth 5YN/A
PM growth 3Y-6.34%
PM growth 5YN/A
GM growth 3Y-11.56%
GM growth 5Y-11%
F-Score7
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 4.28
Debt/EBITDA 1.39
Cap/Depr 94.51%
Cap/Sales 9.87%
Interest Coverage 250
Cash Conversion 82.83%
Profit Quality 84.81%
Current Ratio 1.57
Quick Ratio 1.04
Altman-Z 2.7
F-Score7
WACC7.18%
ROIC/WACC0.95
Cap/Depr(3y)96.67%
Cap/Depr(5y)82.56%
Cap/Sales(3y)9.12%
Cap/Sales(5y)7.68%
Profit Quality(3y)98.85%
Profit Quality(5y)204.67%
High Growth Momentum
Growth
EPS 1Y (TTM)30.49%
EPS 3Y-10.45%
EPS 5YN/A
EPS Q2Q%614.29%
EPS Next Y-54.6%
EPS Next 2Y-6.64%
EPS Next 3Y7.94%
EPS Next 5Y20.99%
Revenue 1Y (TTM)-8.44%
Revenue growth 3Y-9.43%
Revenue growth 5Y30.31%
Sales Q2Q%-15.06%
Revenue Next Year-16.99%
Revenue Next 2Y-6.2%
Revenue Next 3Y-5.57%
Revenue Next 5YN/A
EBIT growth 1Y-6.76%
EBIT growth 3Y-24.54%
EBIT growth 5YN/A
EBIT Next Year104.22%
EBIT Next 3Y32.47%
EBIT Next 5Y22.21%
FCF growth 1Y-21.3%
FCF growth 3Y-24.43%
FCF growth 5YN/A
OCF growth 1Y-10.9%
OCF growth 3Y-10.31%
OCF growth 5Y97.62%

CENOVUS ENERGY INC / CVE Fundamental Analysis FAQ

What is the fundamental rating for CVE stock?

ChartMill assigns a fundamental rating of 4 / 10 to CVE.


What is the valuation status of CENOVUS ENERGY INC (CVE) stock?

ChartMill assigns a valuation rating of 2 / 10 to CENOVUS ENERGY INC (CVE). This can be considered as Overvalued.


What is the profitability of CVE stock?

CENOVUS ENERGY INC (CVE) has a profitability rating of 4 / 10.


Can you provide the financial health for CVE stock?

The financial health rating of CENOVUS ENERGY INC (CVE) is 5 / 10.


What is the earnings growth outlook for CENOVUS ENERGY INC?

The Earnings per Share (EPS) of CENOVUS ENERGY INC (CVE) is expected to decline by -54.6% in the next year.